- Home
- PGC vs SAGE Comparison
PGC vs SAGE Comparison
Compare PGC & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- SAGE
- Stock Information
- Founded
- PGC 1921
- SAGE 2010
- Country
- PGC United States
- SAGE United States
- Employees
- PGC N/A
- SAGE N/A
- Industry
- PGC Commercial Banks
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- PGC Finance
- SAGE Health Care
- Exchange
- PGC Nasdaq
- SAGE Nasdaq
- Market Cap
- PGC 510.8M
- SAGE 413.9M
- IPO Year
- PGC N/A
- SAGE 2014
- Fundamental
- Price
- PGC $27.42
- SAGE $6.46
- Analyst Decision
- PGC Strong Buy
- SAGE Hold
- Analyst Count
- PGC 2
- SAGE 19
- Target Price
- PGC $38.50
- SAGE $9.88
- AVG Volume (30 Days)
- PGC 84.9K
- SAGE 815.0K
- Earning Date
- PGC 07-22-2025
- SAGE 04-29-2025
- Dividend Yield
- PGC 0.73%
- SAGE N/A
- EPS Growth
- PGC N/A
- SAGE N/A
- EPS
- PGC 1.80
- SAGE N/A
- Revenue
- PGC $227,831,000.00
- SAGE $47,404,000.00
- Revenue This Year
- PGC $29.32
- SAGE $103.73
- Revenue Next Year
- PGC $17.18
- SAGE $41.15
- P/E Ratio
- PGC $15.23
- SAGE N/A
- Revenue Growth
- PGC 9.82
- SAGE N/A
- 52 Week Low
- PGC $20.30
- SAGE $4.62
- 52 Week High
- PGC $37.88
- SAGE $13.47
- Technical
- Relative Strength Index (RSI)
- PGC 45.06
- SAGE 38.73
- Support Level
- PGC $27.01
- SAGE $6.36
- Resistance Level
- PGC $28.03
- SAGE $6.78
- Average True Range (ATR)
- PGC 0.72
- SAGE 0.24
- MACD
- PGC -0.15
- SAGE -0.01
- Stochastic Oscillator
- PGC 32.22
- SAGE 12.22
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Wealth Management Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and Internet banking services. Wealth Management includes investment management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services. The services provided by the company include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, individual retirement accounts, and other services.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.